CIK 0001600620 · Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981231763
- Phone
- 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $546,373
- in 2 filings
Net −$546,373. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-21 | Bailey Jeffrey Allen Director | Grant or award | +12,135 | 25,491 | ||
| 2024-11-21 | Bailey Jeffrey Allen Director | Grant or award · Director Stock Option (right to buy) | +18,641 | 18,641 | ||
| 2024-11-21 | Jayne David R.W. Director | Grant or award | +12,135 | 56,499 | ||
| 2024-11-21 | Jayne David R.W. Director | Grant or award · Director Stock Option (right to buy) | +18,641 | 18,641 | ||
| 2024-11-11 | Bailey Jeffrey Allen Director | Sale | −4,557 | $8.43 | $38K | 13,356 |
| 2024-11-11 | Smith Karen L. Director | Sale | −5,241 | $8.43 | $44K | 12,672 |
| 2024-11-08 | Bailey Jeffrey Allen Director | Option exercise | +17,913 | 17,913 | ||
| 2024-11-08 | Bailey Jeffrey Allen Director | Option exercise · Restricted Stock Units | −17,913 | 0 | ||
| 2024-11-08 | Smith Karen L. Director | Option exercise | +17,913 | 17,913 | ||
| 2024-11-08 | Smith Karen L. Director | Option exercise · Restricted Stock Units | −17,913 | 0 | ||
| 2024-08-06 | Habig Scott Michael Chief Commercial Officer | Sale | −18,249 | $5.31 | $97K | 456,338 |
| 2024-05-21 | Balakrishnan Brinda Director | Sale | −520 | $5.74 | $3K | 17,523 |
| 2024-05-21 | Billen Daniel Director | Sale | −5,252 | $5.74 | $30K | 28,141 |
| 2024-05-21 | Jayne David R.W. Director | Sale | −4,946 | $5.74 | $28K | 44,364 |
| 2024-05-21 | Leversage Jill Director | Sale | −5,610 | $5.74 | $32K | 12,918 |
| 2024-05-21 | MacKay-Dunn R. Hector Director | Sale | −5,630 | $5.74 | $32K | 18,595 |
| 2024-03-06 | Greenleaf Peter Chief Executive Officer | Sale | −126,981 | $5.60 | $711K | 1,522,114 |
| 2024-03-06 | Miller Joseph M Chief Financial Officer | Sale | −34,811 | $5.60 | $195K | 495,928 |
| 2024-03-06 | Donley Matthew Maxwell EVP, Ops & Strategy | Sale | −40,665 | $5.51 | $224K | 584,072 |
| 2024-03-06 | Habig Scott Michael Chief Commercial Officer | Sale | −17,777 | $5.60 | $100K | 474,587 |
Page 6 of 10 · 197 trades